Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH)
| 94.90 Data as of 4:00pm ET |  -1.41 / -1.47%Today’s Change | 70.92 Today|||52-Week Range 97.40 | +21.06% Year-to-Date |
Investment Objective
The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care Total Return. The fund will invest at least 90% of its net assets, plus any borrowings for investment purposes, in the equity securities included in the underlying index. The underlying index is an unmanaged equal weighted version of the S&P 500 Health Care Index that consists of the common stocks of the following industries: health care equipment and supplies, health care providers and services, and biotechnology and pharmaceuticals that comprise the Health Care sector of the S&P 500 Index. It is non-diversified.
Latest RYH News
No recent news for Guggenheim S&P 500 Equal Weight Healthcare ETF.
Performance
| 1 month | +0.59% | 3 years | +20.30% | |
| 3 months | +10.24% | 5 years | +14.15% | |
| 1 year | +33.04% | Since inception | +11.20% |
Data through 06/19/2013
Quote Details
| Previous close | $96.31 |
| Open day’s range | 94.90 – 96.54 |
| Net asset value (NAV) | 96.35 (06/18/2013) |
| Daily volume | 7,036 |
| Average volume (3 months) | 17,731 |
Data as of 4:00pm ET, 06/19/2013
Peer Comparisonvs. Health ETFs
| RYH | Category | |
|---|---|---|
| Performance 5-yr return | +14.15% | +13.03% |
| Expense Gross exp ratio | 0.50% | 0.47% |
| Risk 5 year sharpe ratio | 0.75 | 0.76 |
| Net assets | $127.6M | $762.0M |
| Average market cap | $21.5B | $19.5B |
| Average P/E | 19.3 | 21.7 |
| Dividend / Share | -- | 0.22% |
Competitors
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR Fund |
| IXJ iShares S&P Global Healthcare Index Fund |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 96.05% |
| Hardware | 1.99% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
Top 10 HoldingsPortfolio weighting
| ACT Actavis Inc | 2.45% |
| BIIB Biogen Idec Inc | 2.40% |
| BSX Boston Scientific, Inc. | 2.15% |
| BMY Bristol-Myers Squibb Company | 2.14% |
| REGN Regeneron Pharmaceuticals, Inc. | 2.14% |
| WLP WellPoint Inc | 2.13% |
| LIFE Life Technologies Corp | 2.13% |
| GILD Gilead Sciences Inc | 2.09% |
| AET Aetna Inc | 2.08% |
| HUM Humana | 2.07% |